Elite Clinical Studies

What Elite Clinical Studies does

Elite Clinical Studies is a privately-held, multi-specialty Site Management Organization (SMO) and dedicated clinical research facility operating from a 4,500 square foot, three-building campus in Phoenix, Arizona. The firm conducts Phase I–IV clinical trials on behalf of pharmaceutical and biotechnology sponsors, with affiliated Research Specialists of Arizona LLC extending the model into physicians' own offices under back-office, regulatory, and SOP support. Its service stack comprises patient recruitment (leveraging a long-tenured participant database covering most major therapeutic indications), GCP-compliant study design and conduct led by a roster of board-certified principal investigators, and ALCOA-compliant data collection aligned with FDA 21 CFR Part 11. The company self-reports 25+ years of operating history (with a public founding reference of 1998 and firmographic founding of 2009) and currently runs more than 25 active trials across addiction, cardiovascular, gastrointestinal, dermatological, respiratory, metabolic, and inflammatory indications.

Revenue is generated on a professional-services basis through per-trial site fees from sponsors, with no publicly disclosed pricing tiers and no app, API, or software revenue streams. Go-to-market is sales-led: sponsors are engaged directly while patients are recruited via an in-house database, organic and paid social media (Facebook, Instagram), advertising, and community outreach across the Phoenix metro (Phoenix, Tempe, Scottsdale, Mesa, Paradise Valley, Litchfield Park, Glendale, Peoria). The company is privately owned; Managing Partner/Owner Diane J. Saine (CCRC) leads operations alongside Certified Principal Investigator Joseph L. Lillo, D.O., with functional directors covering regulatory, operations, and clinic management, and a specialty bench of board-certified PIs across family practice, cardiology, dermatology, emergency medicine, ophthalmology, orthopedics, and otolaryngology. No venture, PE, or strategic investment, acquisitions, product launches beyond continued trial enrollment, or geographic expansion outside the Phoenix metro are evidenced.

The SMO model relies on three structural assets: a credentialed PI bench with decades of cumulative experience, a proprietary multi-indication participant database, and specialty-ready physical infrastructure (on-site pharmacy, laboratory, advanced imaging including CT, MRI, SPECT, bone densitometry, EMG/NCV, surgical suite with endoscopy, and sleep lab) under 24-hour surveillance. These assets are reusable across successive trials, which is the primary economic engine of the business.

Name

Elite Clinical Studies

Legal name

Elite Clinical Studies LLC

Website

https://eliteclinicalstudies.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Site Network Operators & SMOs (HLAGACAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Site Identification & Feasibility (HLAGACAB), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical trial services
• Site management organization
• Patient recruitment services
• Clinical research facility
• Pharmaceutical trial conduct

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Services: Revenue is generated by conducting clinical trials for pharmaceutical and biotechnology companies (sponsors). The company provides end-to-end support including patient recruitment, study design and conduct, and data collection services. Participants may receive compensation for their time and travel expenses.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Elite Clinical Studies operates as a multi-specialty Site Management Organization (SMO) in Phoenix, Arizona, conducting Phase I-IV clinical trials for pharmaceutical and biotechnology sponsors. The company provides end-to-end clinical trial services including patient recruitment through an extensive participant database, study design and conduct led by Principal Investigators and Study Coordinators, and ALCOA-compliant data collection following 21 CFR Part 11 FDA guidelines.

Product overview

Elite Clinical Studies is a multi-specialty dedicated clinical research facility in Phoenix, Arizona offering a unified platform of clinical trial services. The core offering includes patient recruitment (leveraging an extensive participant database), study design and conduct (with GCP-compliant Principal Investigators and Study Coordinators), and ALCOA-compliant data collection. The company manages over 25 active clinical trials across diverse therapeutic areas including addiction, cardiovascular, gastrointestinal, dermatological, respiratory, metabolic, and inflammatory conditions. The facility provides state-of-the-art infrastructure with examination rooms, monitoring areas, on-site pharmacy, and laboratory facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Studies

Quantifiable outcome

• ALCOA-compliant data management ensuring Attributable, Legible, Contemporaneous, Original, and Accurate data

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves3 records

Expansion highlights3 records

Emerging players

• PRAXIS Health Research: PRAXIS operates a multi-therapeutic SMO/site network with a similar profile of independent investigator partnerships. Comparable as a multi-specialty dedicated research site network competing for sponsor trials in a similar revenue tier.
• Bio-Kinetic Clinical Research: Bio-Kinetic operates dedicated Phase I-IV research facilities with a multi-specialty orientation and integrated participant recruitment, comparable in scale and therapeutic breadth to Elite Clinical Studies.

Direct peers

• Meridian Clinical Research: Meridian operates a dedicated multi-specialty clinical research site network with strong therapeutic breadth and an integrated participant database, directly comparable to Elite Clinical Studies' model. Both compete in the multi-specialty independent SMO segment.
• Accel Research Sites: Accel is a multi-specialty SMO network operating across the southeastern U.S. with a comparable database-driven recruitment model and multi-therapeutic footprint. Directly comparable to Elite Clinical Studies in operating model.

Broad incumbents

• Velocity Clinical Research: Velocity is one of the largest U.S. site networks, operating 30+ dedicated research sites across multiple therapeutic areas. It is the scaled incumbent that Elite Clinical Studies competes against for sponsor placement decisions.
• Ceutical Laboratories / Cenexel Research Sites: Cenexel is a scaled integrated SMO/CRO site network with multiple Phase I-IV units across the U.S. It competes with Elite Clinical Studies for high-value sponsor trials and represents the consolidation trajectory in the SMO space.
• PPD / Thermo Fisher Clinical Research Site Services: PPD (now part of Thermo Fisher) operates a global site network and CRO that competes with independent SMOs for sponsor-awarded Phase II-IV trials. Represents the large-end peer for sponsor relationships.
• ICON plc (PRA Health) Site Solutions: ICON is a global CRO with embedded site management operations that compete with independent SMOs for sponsor trial placement. Represents a scaled peer in clinical trial execution services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/eliteclinicalstudiesaz
• Instagraminstagram.com/elite_clinical_studies
• LinkedInlinkedin.com/company/elite-clinical-studies

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elite Clinical Studies